RCM
WST icon

Rutabaga Capital Management’s West Pharmaceutical WST Stock Holding History

Rutabaga Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-246,131
Closed -$11M – 73
2014
Q3 		$11M Buy
246,131
+8,300
+3% +$353K 1.1% 45
2014
Q2 		$10M Buy
237,831
+7,135
+3% +$306K 0.95% 51
2014
Q1 		$10.2M Buy
230,696
+4,427
+2% +$208K 0.98% 51
2013
Q4 		$11.1M Sell
226,269
-30,842
-12% -$1.44M 1.07% 46
2013
Q3 		$10.6M Sell
257,111
-16,185
-6% -$617K 1.15% 45
2013
Q2 		$9.6M Buy
+273,296
New +$8.99M 1.22% 44

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Rutabaga Capital Management's WST Position: Q4 2014 in Review

Rutabaga Capital Management sold out of West Pharmaceutical (WST) in Q4 2014, closing a stake of 246,131 shares — an estimated $11M sold.

Rutabaga Capital Management first reported a position in WST in Q2 2013 and held it in 6 quarters. The position peaked at $11.1M in Q4 2013. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

  • Rutabaga Capital Management reported no remaining West Pharmaceutical position as of Q4 2014 after selling out during the quarter.
  • Rutabaga Capital Management sold 246,131 West Pharmaceutical shares in Q4 2014, an estimated $11M.
  • Rutabaga Capital Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 6 quarters.
  • Rutabaga Capital Management's West Pharmaceutical position peaked at $11.1M in Q4 2013.
  • 225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on Rutabaga Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.